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Materials and Methods
Mice and Tumors. SjL/j mice were purchased from The Jackson Laboratory (Bar Harbor, Maine). All F1 hybrid mice were bred in our animal facilities. The strains used and their H-2 locus subregions have been outlined in Table I . The RCS-5 and RCS-19 tumors originated from spontaneous RCS in SJL/J mice and were transformed into transplantable lines by Carswell et al. (6, 7) ; transplantable RCS-X was derived from a primary tumor of an SjL/j mouse in our laboratory. RCS-5 and RCS-X have been maintained by serial intravenous passage of ~ 107 tumor-infiltrated LN cells into syngeneic young mice, at weekly intervals. RCS-19 has been passaged intraperitoneally at 10 v cells. For determination of growth in F1 hybrids RCS-5 or RCS-X LN tumor cells were injected intravenously, 7 d after passage, at 10 v cells per mouse, into groups of five mice. Because growth of RCS tumor occurs primarily in peripheral lymphoid organs, weights of spleen and mesenteric, brachial, and axillary LN, determined 7 d after injection and expressed as percentage of body weight, were used as indices of tumor growth, y-Irradiated tumor cells (10,000 y-RCS) were used to control for apparent growth, i.e., LN and spleen weight increases as a result of the proliferative response to RCS in vivo (4) . Therefore, in each experiment an additional group of three mice were injected with I0 T y-RCS, and the percentages of LN and spleen weights in terms of body weight in these mice were subtracted from those obtained in mice injected with unirradiated RCS. Thus, the following formula was used to express growth in Fl hybrids as percentage of growth in SjL/j mice: Cells used for stimulation of a proliferative response were y-irradiated RCS cells (6,000 R, 137Cs source, Radiation Machinery Corp., Parsippany, N. J.). Responder cells were used at 2 × 10 s cells/well, (106 cells/ml), whereas irradiated RCS stimulator cells were used at 5 × 104 cells/ well. In all experiments nonspecific stimuli were used as a measure of lymphocyte reactivity. These included a 72-h incubation with concanavalin A (Con A 5 #g/ml: Miles-Yeda, Miles Laboratories Inc., Elkhart, Ind.) and phytohemagglutinin (PHA) (PHA-P, 5 /xg/ml; Difco Laboratories, Detroit, Mich.). Results of RCS stimulation were considered valid only when Con A and PHA induced appropriate stimulation. Thymidine incorporation (as counts per minute) into cell DNA was measured in five replicate cultures. 1 btCi of [aH]thymidine, (0.36 Ci/mmol, Schwartz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.) was added to each well on day 3 of culture. On day 4, the cultures were collected on glass fiber filter disks (H. Reeve Angel & Co., Inc., Clifton, N. J.) with an automated cell harvester. Radioactivity was measured in a Packard tricarb scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.), using Scintiverse (Fisher Scientific Co., Pittsburgh, Pa.) liquid scintillator cocktail. Proliferative responses to RCS were expressed as increases in counts per minute over the counts per minute in control cells cultured in the absence of stimulation. Responses of LN cells from F1 hybrid mice were expressed as percentages of the response obtained with SJL/J LN cells cultured simultaneously and stimulated with the same y-RCS preparation:
Percent proliferative response _-(FI hybrid + y-RCS mixed) cpm -(F~ hybrid cpm + y-RCS cpm) × 100. (SJL/J + y-RCS mixed) cpm -(SJL/j cpm + y-RCS cpm)
Results were expressed as means + standard errors (n).
MIXED LYMPHOCYTE CULTURES WITH NORMAL SYNGENEIC STIMULATOR CELLS.
Stimulator cells in these cultures were treated with mitomycin C (Drug Synthesis Branch Division of Cancer Treatment, National Cancer Institute, Bethesda, Md.). To enhance the response of LN cells to mitomycin-treated syngeneic spleen cells, 4% (wt/vol) polyethylene glycol (PEG), 6,000 mol wt (Sigma Chemical Co., St. Louis, Mo.), was added to the culture medium (8) . 2 X 105 F1 hybrid nylon wool (9) nonadherent LN cells were used as responder cells and were cultured with mitomycin-treated (25 #g/ml, 45 rain at 37°C) syngeneic, parental, or allogeneic spleen cells (2 X l0 p) or with mitomycin-treated (60/~g/ml, 45 min at 37°C) RCS cells (4 X 104) (Table II) .
Results

Growth of RCS in
Various Parameters of RCS Growth in 171 Hybrids. The effect of time after RCS
injection was further examined in some permissive as well as nonpermissive FI hybrids. SJL/J mice usually die before the 10th d after injection of 10 7 RCS cells, but most of the Fl hybrids survived at least until day 14. The results in Table III (expressed as  percentage (Table IV) . Injections of 104 RCS cells, although causing at least temporary growth in SJL mice, did not result in detectable growth, even in SJL × B6 (data not shown).
Although by far the majority of experiments were carried out with the tumor line RCS-5, a comparison was made with RCS-X and RCS-19 in a permissive (SJL × B6) and in a nonpermissive strain (SJL × BALB/c). The results in Table IV show that the three RCS lines all grew well in the F1 of B6, whereas none of the lines grew in the F1 of BALB/c. Previous studies on induction ofT-cell cytotoxicity and on proliferative responses to y-RCS (1, 4) have also failed to detect differences between these separate transplantable lines.
It should also be noted that SJL/J by other parent invariably gave identical RCS growth, as did the reciprocal F1 hybrids, (data not shown).
Effect on RCS Growth of Whole Body y-Irradiation of the Host before RCS Injection. F1
hybrid mice that were relatively permissive for RCS growth showed a similar inability to grow the tumor when they were irradiated before RCS injection, as was previously described for SJL/J mice themselves (5, 10) . In a series of experiments with SJL × B6 mice, for instance, mice that had been irradiated with 650 R 1 d before tumor cell 10 7 BALB/c <1% <1% ND ND ND <1%
* Growth was expressed as (organ/body weight) × 100 after injection of live tumor from which was subtracted the value for (organ/body weight) × 100 after injection of X-irradiated (10,000 R) tumor. injection showed spleen sizes that were only 33-42% of those in unirradiated mice 1 wk after RCS injection. Comparable experiments in SJL mice showed a somewhat greater reduction in growth, to 26% of the unirradiated SJL mice (data not shown).
Further Examination of the H-2Dd-End Effect. Measures to counteract an effect
mediated by the Hh genes of classical F1 hybrid resistance (11) include treatment with silica (12, 13), carrageenan (14, 15) , or cyclophosphamide (16) . In a previous study (17) all these M cell-inhibiting agents were shown to inhibit RCS growth in SJL mice (5), which was interpreted as showing a helping effect of cells with the properties of M cells on RCS growth. It was therefore not surprising to find that pretreatment with 3 mg silica i.v. in F1 hybrids of SJL by A.TFR4, 7R, or A.TH mice did not enhance RCS growth (data not shown).
The only measure, which is also known to overcome the F1 hybrid resistance linked to the D end and which could be studied here, was that of increasing the tumor dose. The results in Table III with 5 X 107 instead of the usual 107 RCS cells showed that the negative effect of the D end in A.TH was significantly reduced. At this high tumor dose, the I-region effect shown by the comparison between F1 hybrids of SJL with A.TH and A.TL was much greater than it was with the usual dose, whereas the difference between A.SW and A.TH was minimal. Fig. 4 show relative abilities to give this proliferative responsiveness for all the SJL/J F1 hybrids examined.
Ability of LN Cells From Various Fa Hybrids to Give a Proliferative Response to RCS. It was previously found that T cells from certain Fa hybrids of SjL/j mice did not give as good a proliferative response to 3,-irradiated RCS as did T cells from SJL/J mice (1, 4). The results presented in
In general, the ability to give this proliferative response varied in a manner similar to the ability of the F1 hybrids to grow the tumor (Table II) . The most obvious exception to this apparent rule was the lack of effect of the H-2D d end on proliferation in F] hybrids with A background, which contrasted with a -20% effect of this locus on growth. There was a negative effect of the H-2D a end on proliferation in the Fa hybrids with BIO background, but this effect was more variable and less marked than the H-2Da-end effect on growth (Table II) . Because the change of the H-2D end to H-2 a did not completely abolish the proliferative responsiveness, the effect of the I region on the proliferative responses could be measured, whereas its effect on tumor growth could not. Both the A and the BIO backgrounds caused a decrease in proliferative responsiveness, but the effect of the A background was much greater.
It was evident that the I region, both the I-A and I-E/C loci, had a strong effect on the proliferative responsiveness to RCS regardless of genetic backgrounds. Particularly interesting was the observation that H-2 b and H-2 f caused a loss of proliferation, which appeared as a result of the I-A + K regions ( Fig. 4 ; Table II), whereas H-2 k and H-2 d caused negative effects in both the I-A and I-E/C regions. Moreover the effects of the I-A and I-E/C regions appeared additive in the sense that SJL X A.TH and SJL X A.TL (I s vs. I k) differed by 40%, whereas SJL X A.TFR4 and SJL X A.TFR5 (I-E/C f or _s vs. I-E/C k) differed by only 20%. Similarly, SJL X BIO.HTT or 9R were 15-16% below SJL X 7R (I-E/C k or _d vs. I-E/CS), whereas in turn, they were 11-18% above SJL X BIO.A or BIO.A(5R) (K k + I-A k or K b + I-A b vs. K s + I-A s) in ability to proliferate ( Fig. 4 ; Table II) .
Comparison of BIO.S(8R) and BIO.S indicated, however, that the negative effect of K k + I-A k in BIO.A was likely to be an underestimation, because the effect of these same regions was much greater (42%) when regions to the right of I were all s. This also indicated that H-2 k in K + I-A had a larger negative effect than did H-2 b or H-2 f, which even as the complete H-2 regions had barely detectable negative effects. Even without the H-2D a end, H-2 a in K, I, S, and G alone, had a strongly negative effect on both proliferation and growth ( Fig. 4 ; Table II, BIO.HTG vs. BIO). There was no apparent difference between F1 hybrids with BIO.HTT and BIO.(9R), which indicates that the I-J region was relatively unimportant in this phenomenon and that a change in the I-C region from k to d had no effect.
Comparison Between Responses ofF1 T Cells to Syngeneic Parental and RCS Cells.
If the response to y-RCS were an exaggerated form of the syngeneic MLR, a corresponding variability among F1 hybrids in their responsiveness to normal SJL cells could be expected. It seemed important, therefore, to determine whether F~ hybrid T cells could give equally high responses to parental as to syngeneic mitomycin-treated spleen cells.
These responses were all determined in medium that contained PEG because the presence of this agent enhances responses (8) . The results in Table V show that the responses to normal non-T cells of syngeneic and parental origin were approximately equally high for each of the F1 hybrids studied. In contrast, the response to RCS was higher in those strains that also had good responses to RCS without PEG, i.e., SJL X 8R and SJL X A.TH. In the strains that had low to absent responses to RCS without PEG, proliferation to normal SJL spleen and tumor cells was equally high, i.e., SJL × A.TL and SJL X A/J (Table V) . Similarly, the responsiveness of thymus cells to RCS as compared with SJL spleen cells was 100-to 200-fold higher in Fa hybrids with haplotypes that contained I-A-C ~ or -f, or even I-E/C s alone (8R), whereas it was only two-to threefold higher in the ones with I-A-C k or d. These findings suggest that those strains that give high responses to RCS recognize something additional on RCS that is not expressed on normal SJL/J cells and that they recognize as foreign. 
Discussion
The results indicate a variety of genetic influences in F1 hybrids of SJL/J, both on the ability to support RCS growth and on the proliferative responsiveness of LN cells to y-RCS. In the first place there is an effect of background, non-H-2, genes in A, BIO, B6, and less in BALB F1 hybrids that decreases growth. The negative effect of non-H-2 genes on proliferative responses is most evident with A and B6, and is less marked with BALB and BIO backgrounds. The mechanism of this effect has not been examined further. Examples in the literature of non-H-2 influences on tumor induction in F1 hybrids have frequently been related to genes controlling permissiveness to murine leukemia virus infections (18) (19) (20) , but little is known about the possibility that RCS is caused by such a virus in SJL/J mice (21, 22) . Previous studies have not suggested the presence of murine leukemia virus antigens in transplantable RCS lines (2) . In a recent study, Walker and Phillips-Quagliata (23, 24) have described a strong non-H-2 effect on growth of BALB/c plasmacytomas in F1 hybrid mice, which suggests that it might be related to the expression of viral antigens on the tumor cells.
Classical F1 hybrid resistance, as described by Cudkowicz and Bennett (11, 17) , relates to the inability of parental H-2 b bone marrow transplants to grow in F1 hybrids, but also applies to growth of certain lymphomas of H-2 k or H-2 b parental origin (25) (26) (27) (28) . Previous studies of Warner (29) have shown that such F1 hybrid resistance to SjL/j bone marrow and myeloid leukemia is also shown by F1 hybrids of SJL/J with strains carrying H-2 k or H-2 a, but much less in F1 with H-2 b. Thus, F1 hybrid resistance directed against homozygous H-2 S cells similar to the one observed here has been described before. Although originally this type of resistance, regulated or controlled by Hh genes, was thought to map to the right of H-2D, in recent studies on the in vitro form ofF× hybrid resistance (30) , which is accompanied by development of cytotoxicity in vitro, the resistance was mapped to antigens specified by H-2D b and H-2K k (31, 32) . Although some of the background effect may be a result of similar Hh genes, the clear effect of H-2D d, and not of H-2D b, in the F~ hybrids examined in our studies, suggests an Hh gene-effect that results in resistance to H-2 ~, controlled either by H-2D itself or by a locus adjacent to it. Our data do not exclude a similar effect in the H-2K end, particularly in H-2Kk-carrying F1 hybrids.
Natural killer (NK) cells have recently been suggested as the prime mediators of this form of F1 hybrid resistance in vivo (33) (34) (35) (36) . Presumably the effect of H-2D d is less marked on the A than on the BIO background, as shown in our studies, because the A strain has less NK activity (37) . The effect of high tumor cell dosage, partly (on BIO background) or completely (on A background) overriding the H-2Dd-mediated resistance, is in agreement with observations in the literature concerning Hh genemediated FI hybrid resistance (11) . The peculiar behavior of RCS in irradiated SJL/ J mice, in which it does not grow, and in which its growth is facilitated by a cell (or more than one cell type), which is sensitive to silica, carrageenan, and trypan blue (5) precludes a detailed analysis of the effect of these agents on the F1 hybrid resistance. Growth of SJL RCS in the permissive F1 hybrids is also inhibited by these agents and by irradiation of the host before tumor cell injection, as it is in SJL/J mice themselves (5) .
It is of interest that Nakamura and Cudkowicz (38) found a need for "backstimulation" of F1 responders by irradiated T cells in the parental stimulator cells for the induction of a cytotoxic response of F1 anti-parent. It seems likely that the ability of RCS to induce proliferation in Fa cells would enhance the F1 hybrid resistance to RCS growth, but, actually a positive correlation between growth and proliferation was usually seen rather than an inverse correlation. For similar reasons, it is of interest to mention here that RCS was recently observed to produce immune type II interferon (39) . In view of the activating effect of interferon on NK activity (40) this property would also be expected to enhance any FI hybrid resistance that RCS may induce.
The complex effects of the I region on responsiveness of T cells to RCS, and on tumor growth, are of great interest. Previous studies that show I-region effects on tumor growth in F1 hybrids (41) have suggested the presence of immune response genes in this region that regulate cytotoxic or antibody responses against a tumorassociated viral antigen. Although studies are in progress to examine the possibility that Fa hybrids give better immune response to RCS than do SJL/J mice, there are other mechanisms that might account for the I-region effects. Previous studies have indicated that either an antigen closely connected with I-A, or I-A itself, induces the proliferation of syngeneic T cells to RCS, because the presence of anti-I-A in the medium specifically inhibits this response (2) . The decreasing effect on the proliferative responsiveness in F1 hybrids of I-A in apparently all haplotypes other than I-A S, but strongest in I-A k and weakest in LA b, might indicate that a similarity between responder and stimulating cells in the I-A region facilitates this response. Homozygosity in the I-A region could thus increase responsiveness to T-RCS. However, the most striking effect observed is that of the I-E/C region that appears to correspond entirely to the ability of the haplotype to express a product in this region (42) . Thus, a strongly negative effect on proliferation is seen from I-E/C d and I-E/C k, but not from I-E/C b or I-E/C f. It may be argued that the interaction gene product known to occur between I-A and I-E/C (43) , and the resulting influence on I-E/C expression of the molecular form of I-A (44), are sufficiently changing the responder cell surface of the F1 hybrid to make responsiveness impossible. In addition, any negative effect of H-2D a, and possibly also of H-2 k, on the proliferative responsiveness to y-RCS could perhaps he a result of a regulatory effect of Hh genes on the expression of genes in the I region.
h should be realized that a loss of responsiveness of T cells to y-RCS could be either on the basis of a progressive loss of similarity of responder to stimulator cell (assuming a syngeneic interaction between T and B cells by a lock-and key-type mechanism) or, in contrast, on the basis of an increase in similarity. The latter interpretation postulates expression of a normally repressed I-E/C s gene product on RCS cells that is absent from normal SJL/J cells. Thus, the abnormally high response to y-RCS of some F1 mice as compared with the normal syngeneic mixed lymphocyte reaction, which T cells of all F1 mice show to both parental and to F1 non-T-stimulator cells alike (Table V) , would be explained on the basis of an allorecognition by cells from those F1 mice not expressing an interaction product in the I-E/C region. However, if heterozygosity in I-E/C ~ × (k or d) would lead to expression of this postulated I-E/C s product, or else, if the I-E/C k or I-E/C a would be very similar (or identical) to this I-E/C ~ product, then the T cells of F1 hybrids of SJL (H-2 ~) by H-2 k or H-2 d would no longer recognize RCS as foreign and respond, as they do, to RCS and normal SJL/J non-T cells to the same degree. It should be noted that recent studies by others (45, 46 ) indicate the expression of foreign H-2 antigens on tumor cells, and that Roman and Bonavida (47) have described the expression of H-2d-like antigens on in vitro lines of RCS that, however, have some changed properties as compared with the in vivo lines. In our laboratory, no direct evidence for the presence of alien H-2 antigens on in vivo transplantable RCS has been obtained so far.
The correlation between growth and proliferative response still deserves further comment. Analysis of the accessory cell requirements for the RCS growth in SjL/j mice in vivo has led to the suggestion that both T and M cells are needed for its growth (5) . Adult thymectomized, irradiated and bone marrow reconstituted as well as nude mice of SJL/J genotype (48) also show less RCS growth than do normal SJL/J mice (~50% reduction). Thus, the proliferative response may itself in some way facilitate RCS growth in vivo, possibly by activation (3) or via production of growth-promoting soluble mediators.
Summary
Growth of three transplantable reticulum cell sarcomas (RCS) was studied in a variety of F1 hybrids of SJL/J mice by determination of lymph node (LN) and spleen: body weight ratios 7 and 14 d after intravenous injection of RCS cells. Comparison of BIO.S X SJL and A.SW X SJL with SJL/J showed a negative effect of both the A and the BIO non-H-2 genes, particularly on growth in LN. F1 hybrid resistance was noted with F1 hybrids that carried H-2D d and was much more evident with F1 hybrids fi-om BIO-than from A-background mice. This resistance was less marked at 14 than at 7 d and was partially overcome by injection of higher tumor doses. Changing the I region in the F1 parent from H-28 to H-2 b or H-2 f had no effect on growth, but changing to H-2 k or H-2 d virtually abolished the ability to support tumor growth. This effect appeared partially as a result of the I-E/C and partially of the I-A(B) region and was not overcome by higher tumor dose or longer intervals after injection.
There also appeared to be a negative influence on growth of H-2K k, but this was difficult to differentiate from the I-A k effect with the available strains.
The known proliferative responsiveness that SJL/J Lyt-1 T cells exhibit to Ia determinants on ,/-irradiated RCS cells in vitro was also compared with that of cells from various F1 hybrids. Responsiveness of F1 LN cells was expressed as a percentage of the response in SJL/J LN cells to the same RCS cells, measured as [aH]thymidine incorporation. There was a striking degree of correlation between proliferative responsiveness of F1 LN cells to RCS and the ability of the F1 mice to support tumor growth. This correlation was especially clear with respect to the negative influences of non-H-2 genes, and of H-2 loci in the I region, particularly of I-A k or -a and of I-E/ C k or -a, but there also appeared to be a (smaller) negative effect of I-A b or -f Negative influence of H-2D a on growth, however, was not reflected in a similarly large effect on the proliferative response. Additional findings showed that LN cells from all F1 hybrids exhibited equivalent syngeneic mixed lymphocyte responses in the presence of polyethylene glycol to mitomycin-treated spleen cells from both the SJL/ J and the other parent. The extra high response of F1 cells to RCS cells, as compared with SJL spleen cells, however, was always absent when I k or -d was contributed by one of the F1 parents.
The results suggest a promoting effect of the proliferative response on RCS growth in vivo and, furthermore, an interesting effect of I-A and I-E/C genes, possibly via an interaction product, on the ability of LN cells to be stimulated by Ia determinants on RCS cells.
